InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score44
United States Fiscal year ends December CIK 0001787306
$26.58 +8.53% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $26.58 +22.15% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Jan 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Operating income−19.7Net income−19.3Fiscal year 2019Operating income−43.1Net income−42.0EPS, diluted−22.78Fiscal year 2020Revenue0.0Operating income−136.6Net income−135.7EPS, diluted−3.80Fiscal year 2021Revenue0.0Operating income−206.5Net income−206.4EPS, diluted−4.18Fiscal year 2022Revenue3.7Operating income−301.6Net income−311.5EPS, diluted−5.66Fiscal year 2023Revenue59.6 +1,517.1%Operating income−241.1Net income−262.1EPS, diluted−3.78Fiscal year 2024Revenue196.5 +229.7%Operating income−128.4Net income−140.0EPS, diluted−1.16Fiscal year 2025Revenue376.1 +91.3%Operating income−12.2Net income−16.1EPS, diluted−0.13
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 0.0 3.7 59.6 196.5 376.1
Growth +1,517.1% +229.7% +91.3%
Operating income −19.7 −43.1 −136.6 −206.5 −301.6 −241.1 −128.4 −12.2
Net income −19.3 −42.0 −135.7 −206.4 −311.5 −262.1 −140.0 −16.1
Growth
EPS, diluted n/a −22.78 −3.80 −4.18 −5.66 −3.78 −1.16 −0.13

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Operating margin−8,183.0%Net margin−8,449.8%Free cash flow margin−7,000.8%Fiscal year 2023Operating margin−404.5%Net margin−439.8%Free cash flow margin−415.2%Fiscal year 2024Operating margin−65.3%Net margin−71.3%Free cash flow margin−57.1%Fiscal year 2025Operating margin−3.3%Net margin−4.3%Free cash flow margin−1.7%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a −8,183.0% −404.5% −65.3% −3.3%
Net margin n/a n/a n/a n/a −8,449.8% −439.8% −71.3% −4.3%
Free cash flow margin n/a n/a n/a n/a −7,000.8% −415.2% −57.1% −1.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−14.1Capital expenditure0.0Free cash flow−14.1Fiscal year 2019Operating cash flow−42.8Capital expenditure−0.3Free cash flow−43.1Fiscal year 2020Operating cash flow−113.0Capital expenditure−0.3Free cash flow−113.4Fiscal year 2021Operating cash flow−174.6Capital expenditure−1.0Free cash flow−175.6Fiscal year 2022Operating cash flow−257.7Capital expenditure−0.3Free cash flow−258.0Fiscal year 2023Operating cash flow−247.1Capital expenditure−0.4Free cash flow−247.5Fiscal year 2024Operating cash flow−112.2Capital expenditure−0.1Free cash flow−112.3Fiscal year 2025Operating cash flow−5.6Capital expenditure−0.7Free cash flow−6.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −14.1 −42.8 −113.0 −174.6 −257.7 −247.1 −112.2 −5.6
Capital expenditure 0.0 −0.3 −0.3 −1.0 −0.3 −0.4 −0.1 −0.7
Free cash flow −14.1 −43.1 −113.4 −175.6 −258.0 −247.5 −112.3 −6.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash39.4Shareholders’ equity−24.0Fiscal year 2019Cash63.3Shareholders’ equity−65.0Fiscal year 2020Cash65.1Total debt0.0Net cash (debt)65.1Shareholders’ equity270.6Debt to equity0.00Fiscal year 2021Cash96.4Total debt72.4Net cash (debt)24.1Shareholders’ equity297.7Debt to equity0.24Fiscal year 2022Cash53.6Total debt197.8Net cash (debt)−144.1Shareholders’ equity209.6Debt to equity0.94Fiscal year 2023Cash88.4Total debt201.8Net cash (debt)−113.4Shareholders’ equity88.7Debt to equity2.28Fiscal year 2024Cash71.3Total debt107.2Net cash (debt)−35.9Shareholders’ equity157.5Debt to equity0.68Fiscal year 2025Cash42.9Total debt109.0Net cash (debt)−66.1Shareholders’ equity189.5Debt to equity0.58
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 39.4 63.3 65.1 96.4 53.6 88.4 71.3 42.9
Total debt n/a n/a 0.0 72.4 197.8 201.8 107.2 109.0
Net cash (debt) n/a n/a 65.1 24.1 −144.1 −113.4 −35.9 −66.1
Shareholders’ equity −24.0 −65.0 270.6 297.7 209.6 88.7 157.5 189.5
Debt to equity n/a n/a 0.00 0.24 0.94 2.28 0.68 0.58

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Operations
−14.1 −42.8 −113.0 −174.6 −257.7 −247.1 −112.2 −5.6
Growth
Investment
0.0 −0.3 −0.3 −1.0 −0.3 −0.4 −0.1 −0.7
calc −14.1 −43.1 −113.4 −175.6 −258.0 −247.5 −112.3 −6.3
Growth
calc n/a −23.40 −3.18 −3.55 −4.69 −3.57 −0.93 −0.05
−11.5 −26.3 −181.8 −76.0 −87.2 180.2 28.8 −30.3
Financing
61.6 93.1 298.1 281.9 301.8 101.3 66.2 7.0

† The diluted share count jumps at 2020 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.